Fear in Indian pharma over EU’s demand to seize drugs in transit
The Indian pharmaceutical industry is worried over the demands raised by the European Union (EU), as India moves to […]
Pharma
Imported Insulin to cost more
The National Pharma Pricing Authority, the drug regulators have received a deadline of two months to revise its November order […]
World Health Day – April 7, 2013
Dr Margaret Chan, Director-General , World Health Organization “We live in a rapidly changing environment. Throughout the world, human health […]
Piramal pushing growth in OTC business
Piramal Healthcare, a part of Piramal Enterprises, is expecting to grow its over-the-counter (OTC) business aggressively, and expects it to […]
Dr Reddy’s launches generic Zoledronic Acid injection in US
Drug firm Dr Reddy’s Laboratories today said it has launched generic Zoledronic Acid injection used for treating osteoporosis and Paget’s […]
Study reveals that chemotherapy works in an unexpected way
It’s generally thought that anticancer chemotherapies work like antibiotics do, by directly killing off what’s harmful. But new research published […]
Asprin to fuel USD 100 b pension costs
Aspirin’s use in fighting cancer has the potential to increase pension liabilities by as much as $100 billion by extending […]
Drugs to skip price control for 5 years
Drugs that boast of an element of Indian innovation can skip price control for five years under the proposed new […]
New nanomedicine resolves inflammation, promotes tissue healing
A multicenter team of researchers, including scientists at Columbia University Medical Center (CUMC), Brigham and Women’s Hospital (BWH), Mount Sinai […]
World Autism Awareness Day – April 2, 2013
Secretary-General’s Message for 2013 :: “World Autism Awareness Day has succeeded in calling greater international attention to autism and other […]
Opto Circuits’ subsidiary, Cardiac Science, rationalizes its product offering by spinning off its Diagnostic Cardiology product line
Cardiac Science, an Opto Circuits group company, signed a definitive agreement on 29th March 2013 to sell its Diagnostic Cardiology […]
Physicians prefer a shielded EHR view
Even as policymakers are pushing patient engagement, a new survey signals doctors may not be ready to relinquish control of […]
Ranbaxy resumes supply of Atorvastatin tablets in US market
Drug major Ranbaxy Laboratories on Monday said it has resumed the supply of Atorvastatin calcium tablets, a cholesterol lowering drug, […]
